Gambling prevalence and practices in France in 2010
Tendances n° 77, OFDT, 8 p.
In France, there have been several recent public reports (Trucy, 2006; INSERM, 2008) on gambling. The purpose of these reports was not only to examine the economic impact of gambling, but also the public health impact, given the personal and social problems that may result from problem gambling.
However, the scope of these problems was not quantified. In order to fill this informational gap, the public authorities commissioned the OFDT to carry out the first national gambling prevalence survey in France. This survey was conducted as part of the INPES (the French National Institute for Prevention and Health Education) Baromètre santé 2010 health survey. The objective was to gather data on the number of gamblers, both occasional and regular, and to estimate the size of the problem gambling or pathological gambling population. Since this estimate only pertained to the period preceding the opening up of the French online gambling market to competition (French law of 12 May 2010), it cannot be used to measure the impact of this legislation on the prevalence of problem or pathological gambling.
Jean-Michel Costes, Maud Pousset, Vincent Eroukmanoff, Olivier Le Nezet, Jean-Baptiste Richard, Romain Guignard, François Beck, Pierre Arwidson
Download the PDF file (425 Ko)
Drugs in Europe
- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe
Country situation summaries
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.